Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.3873 +0.0031 (+0.81%)
Streaming Delayed Price Updated: 1:43 PM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
The Bull Lives Below $1: PRSO, ENSC, TNMG, QNME Stocks to Watch
Via AB Newswire
Topics Artificial Intelligence
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
These stocks are making the most noise in today's session. ↗
Via Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
News headline image
Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study
From Ensysce Biosciences
Via ACCESS Newswire
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. Adagio Medical Holdings... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock rose 118.1% to $0.61 during Monday's after-market session. The market value of their outstanding shares is at $3.8 million. TransCode Therapeutics... 
Via Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant
From Ensysce Biosciences
Via ACCESS Newswire
News headline image
Ensysce Biosciences Reports First Quarter 2026 Financial Results
Via ACCESS Newswire
News headline image
Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
Via ACCESS Newswire
Check out the stocks that are attracting the most attention and driving market activity. ↗
Via Chartmill
News headline image
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
Via ACCESS Newswire
News headline image
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
Via ACCESS Newswire
News headline image
These stocks are moving in today's after hours session ↗
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
Via ACCESS Newswire
News headline image
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
Via ACCESS Newswire
Which stocks are moving on Wednesday? ↗
Via Chartmill
News headline image
Ensysce Biosciences Initiates Live "Ask Me Anything" (AMA) Session Highlighting Growth and Future Plans
Via ACCESS Newswire
News headline image
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Top movers in Friday's after hours session ↗
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Discover the most active stocks in Friday's session. ↗
Via Chartmill
News headline image
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Advances QuickStrip™ Research Backed by NFL-Supported Clinical Evaluation – More Stocks Inside
Via AB Newswire
Which stocks are moving on Friday? ↗
Via Chartmill
Gapping stocks in Friday's session ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.